Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer

Discover the groundbreaking insights of Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer, authored by experts in the field and published by John Wiley & Sons Inc in 2010. This award-winning title, which received the first prize in the Oncology category at the 2011 British Medical Association's Medical Book Awards, offers a comprehensive exploration of the latest advancements in targeted cancer therapies.

Spanning an impressive 648 pages, this hardback edition delves into the innovative applications of monoclonal antibodies and peptides in radiotherapy, making it an essential resource for healthcare professionals, researchers, and students alike. Stay informed about the evolving landscape of oncology with this essential guide, designed to enhance your understanding of this dynamic pharmaceutical field.

Enhance your library with this pivotal work and gain valuable knowledge that can impact cancer treatment strategies.